TAU THERAPEUTICS
Tau Therapeutics LLC, a development stage biopharmaceutical company, focuses on the research, development, repositioning, and commercialization of calcium T-channel therapy agents as cytostatic anti-cancer drugs. It offers calcium T-channel blockers for oncology and other diseases. The company was founded in 2003 and is based in Charlottesville, Virginia.
TAU THERAPEUTICS
Industry:
Biotechnology Oncology Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Website Url:
http://www.tautherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
434-974-6969
Total Funding:
12.84 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Mobile Non Scaleable Content Microsoft Exchange Online Liquid Web Microsoft DNS
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Employees Featured
Founder
Official Site Inspections
http://www.tautherapeutics.com
- Host name: host.mytechtailor.com
- IP address: 208.75.148.200
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Tau Therapeutics"
Tay Therapeutics โ Overcoming mutations, treating disease
We turn discovery into action, advancing differentiated small molecule medicines through in-house expertise and strategic partnerships. Our therapies aim to address serious conditions โฆSee details»
Tau Therapeutics - Crunchbase Company Profile & Funding
Organization. Tau Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Tau Therapeutics engages in the โฆSee details»
Tay Therapeutics Ltd | LinkedIn
Tay Therapeutics is a UK-based biotech headquartered in Dundee, overlooking the River Tay. We are dedicated to developing targeted small molecule therapies to address diseases with high โฆSee details»
Tay Therapeutics - 2025 Company Profile - Tracxn
Tay Therapeutics - Developer of therapeutics for genetic diseases and cancer. Raised a total funding of $1.62M over 3 rounds. Founded by Andrew Woodland and Mark Bell in the year โฆSee details»
Tay Therapeutics Ltd - Drug pipelines, Patents, Clinical trials
Taytherapeutics.com. Holding Company | 2020 | United Kingdom | taytherapeutics.com. Last update 08 May 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. ... The statistics โฆSee details»
Tay Therapeutics | Welcome to Bio-Dundee
[email protected]. Description. Delivering first in class therapies for skin disease. We specialize in the discovery of drugs, which are safe and effective, for the treatment of skin โฆSee details»
TAU Therapeutics Company Profile | Management and Employees โฆ
TAU Therapeutics Profile and History. TAU Therapeutics is a clinical stage biopharmaceutical company committed to providing patients with a better way of treating cancer through the โฆSee details»
About us - Tay Therapeutics
Mark Bell is a medicinal chemist with 20 years experience working in biotech and academic settings. He co-founded Tay Therapeutics and led on the discovery of VYN201, a topical soft โฆSee details»
Tau Therapeutics - Products, Competitors, Financials, Employees ...
Tau Therapeutics is a clinical stage company developing oncology drugs for solid tumors that selectively inhibit the T-type calcium channel - a mechanism of action for cancer. Use the CB โฆSee details»
Tay Therapeutics - Crunchbase Company Profile & Funding
Tay-Enableโข A platform for discovering and developing medicines that enable the body to ignore premature stop codon mutations, producing functional proteins for genetic diseases and cancers.See details»
TAY THERAPEUTICS LIMITED - Companies House
TAY THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business โฆSee details»
Spinout agrees potential $50 million deal - University of Dundee
May 2, 2023 The company has agreed the deal with VYNE Therapeutics Inc, a US-based biotech firm focused on developing therapies for immuno-inflammatory diseases. VYNE has โฆSee details»
Tay Therapeutics Announces Licensing to VYNE Therapeutics of
May 2, 2023 For more information, please visit www.taytherapeutics.com or contact Tim Sparey Ph.D (Executive Chair) [email protected] (+44 (0) 7718864561). About VYNE โฆSee details»
Contact โ Tay Therapeutics
Tay Therapeutics Limited Company number: SC651132. Email: [email protected]. Registered Address Dundee University Incubator 3 James Lindsay PlaceSee details»
Tau Therapeutics - Contacts, Employees, Board Members
Tau Therapeutics engages in the R&D, repositioning and commercialization of calcium T-channel therapies for oncology and other diseases.See details»
Tay Therapeutics Ltd (Tay Therapeutics Ltd) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ โฆ
Jun 15, 2025 ไบ่งฃTay Therapeutics Ltd (Tay Therapeutics Ltd)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็49็ฏๆฐ้ป๏ผ็พ็ ้ขๅ:ๅ ็ซ็ณป็ป็พ็ ๏ผๅ ๅๆณไธไปฃ่ฐข็พ็ ๏ผ็ฅ็ป็ณป็ป็พ็ ๏ผ่ฟ โฆSee details»
Tau therapeutics: Clinical development status and future directions ...
Dec 7, 2020 Background. Accumulation of insoluble, misfolded tau protein is a hallmark of AD, chronic traumatic encephalopathy and approximately half of frontotemporal lobar degeneration โฆSee details»
Pipeline โ Tay Therapeutics
TAY-B1 (Repibresib): Locally Active BET Inhibitor. TAY-B1 is a first-in-class, locally active BET bromodomain inhibitor (BRD2, BRD3, BRD4, BRDT) designed to effectively target โฆSee details»
Revisiting the therapeutic landscape of tauopathies: assessing the ...
Jun 4, 2025 Microtubule associated protein tau (MAPT) is a naturally occurring protein that plays a significant role in stabilizing microtubules, which are essential for the transport of nutrients โฆSee details»
Science โ Tay Therapeutics
Restoring Protein Synthesis. In normal cells, mRNA is translated by the ribosome into a chain of amino acids, producing functional proteins. A nonsense mutation introduces a premature stop โฆSee details»